136 related articles for article (PubMed ID: 38556267)
21. Patent foramen ovale in idiopathic pulmonary arterial hypertension: Long-term risk and morbidity.
Gallo de Moraes A; Vakil A; Moua T
Respir Med; 2016 Sep; 118():53-57. PubMed ID: 27578471
[TBL] [Abstract][Full Text] [Related]
22. [Echocardiography and other imaging modalities in pulmonary arterial hypertension].
Ozben B; Başaran Y
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():27-35. PubMed ID: 20819764
[TBL] [Abstract][Full Text] [Related]
23. Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension.
Ahmed A; Ahmed S; Rådegran G
Pulm Circ; 2021; 11(4):20458940211041500. PubMed ID: 34616545
[TBL] [Abstract][Full Text] [Related]
24. Predictive Value of Pulmonary Arterial Compliance in Systemic Lupus Erythematosus Patients With Pulmonary Arterial Hypertension.
Guo X; Lai J; Wang H; Tian Z; Zhao J; Li M; Fang Q; Fang L; Liu Y; Zeng X
Hypertension; 2020 Oct; 76(4):1161-1168. PubMed ID: 32772648
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life in patients with pulmonary arterial hypertension.
Taichman DB; Shin J; Hud L; Archer-Chicko C; Kaplan S; Sager JS; Gallop R; Christie J; Hansen-Flaschen J; Palevsky H
Respir Res; 2005 Aug; 6(1):92. PubMed ID: 16092961
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary arterial hypertension in children.
Rosenzweig EB; Widlitz AC; Barst RJ
Pediatr Pulmonol; 2004 Jul; 38(1):2-22. PubMed ID: 15170869
[TBL] [Abstract][Full Text] [Related]
27. Prevalence, Diagnosis, Perioperative Monitoring and Treatment of Right Ventricular Dysfunction and/or Pulmonary Arterial Hypertension in Cardiac Surgical Patients in Germany-A Postal Survey.
Heringlake M; Schön J; Pliet T; Haake N; Reinecke A; Habicher M; Sander M; Markewitz A; Reuter DA; Groesdonk HV; Trummer G; Pilarzyk K; von der Brelie M; Bein B; Schirmer U
Thorac Cardiovasc Surg; 2017 Dec; 65(8):593-600. PubMed ID: 26909559
[No Abstract] [Full Text] [Related]
28. Assessment of Risk of Disease Progression in Pulmonary Arterial Hypertension: Insights from an International Survey of Clinical Practice.
Simons JE; Mann EB; Pierozynski A
Adv Ther; 2019 Sep; 36(9):2351-2363. PubMed ID: 31313097
[TBL] [Abstract][Full Text] [Related]
29. Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
Charoenpong P; Dhillon N; Murnane K; Goeders N; Hall N; Keller C; Bhuiyan MAN; Walter R
BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38061804
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB
Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary Arterial Hypertension Secondary to Drugs and Toxins.
Ramirez RL; Pienkos SM; de Jesus Perez V; Zamanian RT
Clin Chest Med; 2021 Mar; 42(1):19-38. PubMed ID: 33541612
[TBL] [Abstract][Full Text] [Related]
32. Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension.
Stolfo D; Albani S; Biondi F; De Luca A; Barbati G; Howard L; Lo Giudice F; Tsampasian V; Pasanisi EM; Airò E; Bauleo C; Emdin M; Sinagra G
J Am Soc Echocardiogr; 2020 Nov; 33(11):1334-1344.e2. PubMed ID: 32747222
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary arterial hypertension.
Luna-López R; Ruiz Martín A; Escribano Subías P
Med Clin (Barc); 2022 Jun; 158(12):622-629. PubMed ID: 35279313
[TBL] [Abstract][Full Text] [Related]
34. Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension.
Olsson KM; Richter MJ; Kamp JC; Gall H; Heine A; Ghofrani HA; Fuge J; Ewert R; Hoeper MM
J Heart Lung Transplant; 2019 Jul; 38(7):748-756. PubMed ID: 31128966
[TBL] [Abstract][Full Text] [Related]
35. Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus.
Lei Y; Zhang X; Feng Y; Wang J; Luo R
Cardiol Young; 2021 Oct; 31(10):1619-1624. PubMed ID: 33682659
[TBL] [Abstract][Full Text] [Related]
36. Single-center prognostic validation of the risk assessment of the 2015 ESC/ERS guidelines in patients with pulmonary arterial hypertension in Japan.
Imai R; Adachi S; Yoshida M; Shimokata S; Nakano Y; Okumura N; Murohara T; Kondo T
Can J Physiol Pharmacol; 2020 Sep; 98(9):653-658. PubMed ID: 32924564
[TBL] [Abstract][Full Text] [Related]
37. Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.
Orozco-Levi M; Cáneva J; Fernandes C; Restrepo-Jaramillo R; Zayas N; Conde R; Diez M; Jardim C; Pacheco Gallego MC; Melatini L; Valdéz H; Pulido T
Pulm Circ; 2022 Jan; 12(1):e12012. PubMed ID: 35506085
[TBL] [Abstract][Full Text] [Related]
38. Idiopathic, heritable and veno-occlusive pulmonary arterial hypertension in childhood: computed tomography angiography features in the initial assessment of the disease.
Berteloot L; Proisy M; Jais JP; Lévy M; Boddaert N; Bonnet D; Raimondi F
Pediatr Radiol; 2019 May; 49(5):575-585. PubMed ID: 30652195
[TBL] [Abstract][Full Text] [Related]
39. Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience.
de Perrot M; Granton JT; McRae K; Pierre AF; Singer LG; Waddell TK; Keshavjee S
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):910-8. PubMed ID: 22306224
[TBL] [Abstract][Full Text] [Related]
40. Assessment of pulmonary valve echogram in normal subjects and in patients with pulmonary arterial hypertension.
Lew W; Karliner JS
Br Heart J; 1979 Aug; 42(2):147-61. PubMed ID: 486275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
